Safety and Efficacy of SPARC1203 in Allergic Rhinitis
NCT01614691 · Status: COMPLETED · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 159
Last updated 2019-05-03
Summary
This study will assess safety and efficacy of SPARC1203 delivered via nasal spray in patients with allergic rhinitis
Conditions
- Allergic Rhinitis
Interventions
- DRUG
-
SPARC1203
Active
- DRUG
-
Placebo
Sponsors & Collaborators
-
Sun Pharma Advanced Research Company Limited
lead INDUSTRY
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- QUADRUPLE
- Model
- PARALLEL
Eligibility
- Min Age
- 18 Years
- Max Age
- 65 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2012-06-30
- Primary Completion
- 2012-11-30
- Completion
- 2013-03-31
Countries
- Germany
Study Locations
More Related Trials
-
Study In Adults And Adolescents With Seasonal Allergic Rhinitis.
NCT00225823 ·Status: COMPLETED ·Phase: PHASE3
-
To Assess the Safety and Efficacy of Ciclesonide, Applied as a Nasal Spray in the Treatment of Seasonal Allergic Rhinitis (BY9010/M1-401)
NCT00659841 ·Status: COMPLETED ·Phase: PHASE3
-
Once-Daily Investigational Nasal Spray In Adults And Adolescents With Seasonal Allergic Rhinitis (SAR)
NCT00197262 ·Status: COMPLETED ·Phase: PHASE3
-
Study of Stapokibart Injection in Patients With Allergic Rhinitis
NCT06525597 ·Status: RECRUITING ·Phase: PHASE2
-
Evaluation of Safety and Efficacy of Specific Immunotherapy With Recombinant Major Allergens of Timothy Grass Pollen Adsorbed Onto Aluminium-hydroxide in Patients With IgE-mediated Allergic Rhinoconjunctivitis +/- Controlled Asthma
NCT00671268 ·Status: COMPLETED ·Phase: PHASE3
-
MK0524 Seasonal Allergic Rhinitis Study (0524-005)(COMPLETED)
NCT00533208 ·Status: COMPLETED ·Phase: PHASE2
-
Study in Adult and Adolescent Subjects With Seasonal Allergic Rhinitis (SAR)
NCT01024608 ·Status: COMPLETED ·Phase: PHASE3
-
Study In Adolescent And Adult Subjects 12 Years Of Age And Older With Seasonal Allergic Rhinitis To Assess Onset of Action
NCT00118729 ·Status: COMPLETED ·Phase: PHASE3
-
Safety and Efficacy Study of rEV131 in Allergic Rhinitis
NCT00247520 ·Status: UNKNOWN ·Phase: PHASE1/PHASE2
-
A Phase III Study to Assess the Efficacy and Safety of PG-011 Nasal Spray in Adults With Moderate to Severe Seasonal Allergic Rhinitis
NCT07146126 ·Status: NOT_YET_RECRUITING ·Phase: PHASE3
-
Evaluation of Efficacy and Safety of Specific Immunotherapy With Modified Allergen Extracts of House Dust Mites
NCT01013116 ·Status: UNKNOWN ·Phase: PHASE3
-
A Study of RO4989991 in Patients With Allergic Rhinitis
NCT01152619 ·Status: COMPLETED ·Phase: PHASE1
-
Safety Study of Olopatadine Nasal Spray
NCT00578331 ·Status: COMPLETED ·Phase: PHASE3
-
Efficacy and Safety of Specific Immunotherapy With CLUSTOID Grass Pollen
NCT01012531 ·Status: COMPLETED ·Phase: PHASE3
-
Seasonal Allergic Rhinitis In Pediatric Subjects
NCT00107757 ·Status: COMPLETED ·Phase: PHASE3
-
Safety and Efficacy Study With Allergen Extracts of House Dust Mites for Specific Sublingual Immunotherapy
NCT01014325 ·Status: UNKNOWN ·Phase: PHASE3
-
Perennial Allergic Rhinitis Study In Pediatric Subjects
NCT00108914 ·Status: COMPLETED ·Phase: PHASE3
-
Study of GW685698X In Patients With Seasonal Allergic Rhinitis
NCT00363740 ·Status: COMPLETED ·Phase: PHASE3
-
Study In Adults And Adolescents With Seasonal Allergic Rhinitis
NCT00115622 ·Status: COMPLETED ·Phase: PHASE3
-
Placebo-Controlled Study of Mometasone Furoate Nasal Spray (MFNS) 200 mcg QD in the Treatment of Seasonal Allergic Rhinitis (Study P05106)(COMPLETED)
NCT00468312 ·Status: COMPLETED ·Phase: PHASE3
-
To Assess the Safety and Efficacy of Ciclesonide Applied as a Nasal Spray in the Treatment of Perennial Allergic Rhinitis (BY9010/M1-402)
NCT00659750 ·Status: COMPLETED ·Phase: PHASE3
-
Clinical Trial to Assess the Efficacy and Safety of Ciclesonide Hydrofluoroalkane (HFA) Nasal Aerosol for the Treatment of Seasonal Allergic Rhinitis
NCT00790023 ·Status: COMPLETED ·Phase: PHASE3
-
Efficacy, Safety & Tolerability of Ciclesonide 200mcg Spray 4 Weeks Treatment for Intermittent & Persistent Rhinitis
NCT01369563 ·Status: COMPLETED
-
A Study to Determine the Optimal Dose and Frequency of ALDP001 Nasal Spray in Adults With Seasonal Allergic Rhinitis Under Allergen Exposure
NCT07219849 ·Status: RECRUITING ·Phase: PHASE2
-
Efficacy and Safety of HCP1102 Capsule in Patients With Perennial Allergic Rhinitis
NCT04324918 ·Status: COMPLETED ·Phase: PHASE3